N
MANE

Nuveen’s Veradermics Inc MANE Stock Holding History

Nuveen’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
+47,894
New +$4.49M ﹤0.01% 2012

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Nuveen's MANE Position: Q2 2026 in Review

Nuveen opened a new position in Veradermics Inc (MANE) in Q2 2026: 47,894 shares worth $5.89M. The stake represents ﹤0.01% of the portfolio and ranks #2012 among its holdings.

55 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Nuveen held 47,894 shares of Veradermics Inc worth $5.89M as of Q2 2026.
  • Veradermics Inc was a new Nuveen position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2012 holding.
  • 55 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.